This site is intended for healthcare professionals only.
Log in
Menu

Latest findings from the ATALANTA-1 trial of GLPG5101

  • EHA 2025
  • Video interview
Speaker: Dr Pim Mutsaers
Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Dr Pim Mutsaers discusses the latest findings from the ATALANTA-1 trial of GLPG5101, which uses a decentralized platform, in patients with R/R NHL.

EHA2025 Congress; Milan, Italy: 12–15 June

https://ehaweb.org/connect-network/eha2025-congress

Log in

Like this content?

Share with a colleague

Before you go...

We want to hear from you! Share your quick feedback

By providing my email I consent to receive e-alerts from Springer Health+ IME pertinent to my area of interest. I can withdraw my consent at any time by contacting [email protected] or via the ‘unsubscribe’ link included in any email communications.

No, thanks (don't show this again)

Register for alerts

Complete the short registration form to be contacted when new learning content is made available, including ASH conference coverage, an “experts in conversation” webcast and free downloadable practice aid.

Log in to sign up for alerts